ArticleGynecologic oncology reports2026

Rescuing a refractory Leiomyosarcoma: ALK-DCTN1 fusion as a gateway to long-term control with Ceritinib.

Francis Yew Fu Tieng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.